June 16, 2020 / 12:34 PM / 21 days ago

BRIEF-Monopar And Northstar To Develop Radio-Immuno-Therapeutics Targeting Severe Covid-19

June 16 (Reuters) - Monopar Therapeutics Inc:

* MONOPAR AND NORTHSTAR JOIN FORCES TO DEVELOP RADIO-IMMUNO-THERAPEUTICS (RITS) TARGETING SEVERE COVID-19

* MONOPAR THERAPEUTICS INC - MONOPAR AND NORTHSTAR PLAN TO COUPLE MNPR-101 TO A THERAPEUTIC RADIOISOTOPE SUPPLIED BY NORTHSTAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below